Joint ESCMID, FEMS, IDSA, ISID and SSI position paper on the fair handling of career breaks among physicians and scientists when assessing eligibility for early-career awards.

Awards Career breaks Diversity Gender balance Medicine Science

Journal

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420

Informations de publication

Date de publication:
18 Feb 2021
Historique:
received: 11 09 2020
revised: 29 01 2021
accepted: 30 01 2021
pubmed: 21 2 2021
medline: 21 2 2021
entrez: 20 2 2021
Statut: aheadofprint

Résumé

Though women increasingly make up the majority of medical-school and other science graduates, they remain a minority in academic biomedical settings, where they are less likely to hold leadership positions or be awarded research funding. A major factor is the career breaks that women disproportionately take to see to familial duties. They experience a related, but overlooked, hurdle upon their return: they are often too old to be eligible for 'early-career researcher' grants and 'career-development' awards, which are stepping stones to leadership positions in many institutions and which determine the demographics of their hierarchies for decades to come. Though age limits are imposed to protect young applicants from more experienced seniors, they have an unintended side effect of excluding returning workers, still disproportionately women, from the running. In this joint effort by the European Society of Clinical Microbiology and Infectious Diseases, the Federation of European Microbiological Societies, the Infectious Disease Society of America, the International Society for Infectious Diseases and the Swiss Society for Infectious Diseases, we invited all European Congress of Clinical Microbiology and Infectious Diseases-affiliated medical societies and funding bodies to participate in a survey on current 'early-career' application restrictions and measures taken to provide protections for career breaks. The following simple consensus recommendations are geared to funding bodies, academic societies and other organizations for the fair handling of eligibility for early-career awards: 1. Apply a professional, not physiological, age limit to applicants. 2. State clearly in the award announcement that career breaks will be factored into applicants' evaluations such that: • Time absent is time extended: for every full-time equivalent of career break taken, the same full-time equivalent will be extended to the professional age limit. • Opportunity costs will also be taken into account: people who take career breaks risk additional opportunity costs, with work that they did before the career break often being forgotten or poorly documented, particularly in bibliometric accounting. Although there is no standardized metric to measure additional opportunity costs, organizations should (a) keep in mind their existence when judging applicants' submissions, and (b) note clearly in the award announcement that opportunity costs of career breaks are also taken into account. 3. State clearly that further considerations can be undertaken, using more individualized criteria that are specific to the applicant population and the award in question. The working group welcomes feedback so that these recommendations can be improved and updated as needed.

Sections du résumé

BACKGROUND BACKGROUND
Though women increasingly make up the majority of medical-school and other science graduates, they remain a minority in academic biomedical settings, where they are less likely to hold leadership positions or be awarded research funding. A major factor is the career breaks that women disproportionately take to see to familial duties. They experience a related, but overlooked, hurdle upon their return: they are often too old to be eligible for 'early-career researcher' grants and 'career-development' awards, which are stepping stones to leadership positions in many institutions and which determine the demographics of their hierarchies for decades to come. Though age limits are imposed to protect young applicants from more experienced seniors, they have an unintended side effect of excluding returning workers, still disproportionately women, from the running.
METHODS METHODS
In this joint effort by the European Society of Clinical Microbiology and Infectious Diseases, the Federation of European Microbiological Societies, the Infectious Disease Society of America, the International Society for Infectious Diseases and the Swiss Society for Infectious Diseases, we invited all European Congress of Clinical Microbiology and Infectious Diseases-affiliated medical societies and funding bodies to participate in a survey on current 'early-career' application restrictions and measures taken to provide protections for career breaks.
RECOMMENDATIONS CONCLUSIONS
The following simple consensus recommendations are geared to funding bodies, academic societies and other organizations for the fair handling of eligibility for early-career awards: 1. Apply a professional, not physiological, age limit to applicants. 2. State clearly in the award announcement that career breaks will be factored into applicants' evaluations such that: • Time absent is time extended: for every full-time equivalent of career break taken, the same full-time equivalent will be extended to the professional age limit. • Opportunity costs will also be taken into account: people who take career breaks risk additional opportunity costs, with work that they did before the career break often being forgotten or poorly documented, particularly in bibliometric accounting. Although there is no standardized metric to measure additional opportunity costs, organizations should (a) keep in mind their existence when judging applicants' submissions, and (b) note clearly in the award announcement that opportunity costs of career breaks are also taken into account. 3. State clearly that further considerations can be undertaken, using more individualized criteria that are specific to the applicant population and the award in question. The working group welcomes feedback so that these recommendations can be improved and updated as needed.

Identifiants

pubmed: 33609786
pii: S1198-743X(21)00056-2
doi: 10.1016/j.cmi.2021.01.029
pmc: PMC9196972
mid: NIHMS1811722
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : K08 AI120806
Pays : United States

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

Am Sci. 2012 Mar 1;100(2):138-145
pubmed: 24596430
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4182-4187
pubmed: 30782835
J R Soc Med. 2014 Apr 16;107(7):259-263
pubmed: 24739380
J Infect Dis. 2020 Sep 14;222(Suppl 6):S543-S549
pubmed: 32926739
Nature. 2020 May;581(7809):365-366
pubmed: 32433639
BMJ. 2005 Sep 10;331(7516):569-72
pubmed: 16150771
PLoS One. 2013 Jun 28;8(6):e68258
pubmed: 23840840
J Infect Dis. 2020 Sep 14;222(Suppl 6):S528-S534
pubmed: 32926743

Auteurs

Angela Huttner (A)

Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland. Electronic address: angela.huttner@hcuge.ch.

Alice Bricheux (A)

Internal Medicine, Geneva University Hospitals, Geneva, Switzerland.

Carianne J M Buurmeijer-van Dijk (CJM)

The Federation of European Microbiological Societies, Delft, the Netherlands.

Matthew Harvey (M)

The Federation of European Microbiological Societies, Delft, the Netherlands.

Alison Holmes (A)

Department of Infectious Disease, Imperial College, London, UK.

Britta Lassmann (B)

International Society for Infectious Diseases, Brookline, MA, USA.

Valéry Lavergne (V)

Research Centre, Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l'île-de-Montréal, Hôpital du Sacré-Coeur de Montréal, University of Montreal, Montreal, Quebec, Canada; Department of Clinical Affairs & Practice Guidelines, Infectious Disease Society of America, Arlington, VA, USA.

Alexandra Mailles (A)

Santé Publique France, Direction des maladies infectieuses, Saint Maurice, France.

Marc Mendelson (M)

Division of Infectious Diseases & HIV Medicine, University of Cape Town, South Africa.

Nicolas Muller (N)

Division of Infectious Diseases, Zurich University Hospital, Zurich, Switzerland.

Maurizio Sanguinetti (M)

Department of Laboratory Sciences and Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Cynthia Sears (C)

Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD, USA.

Chrysanthi Skevaki (C)

Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, German Centre for Lung Research (DZL), Marburg, Germany.

Uzma Syed (U)

South Shore Infectious Diseases and Travel Medicine Consultants & Antibiotic Infusion Center, Bayshore, NY, USA.

Salandra Thomas (S)

Infectious Disease Society of America, Arlington, VA, USA.

Talia H Swartz (TH)

Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Classifications MeSH